|
雷帕霉素药物洗脱支架PARTNER与Cypher治疗冠心病的临床对比观察 |
| |
ts compared with conventional bare stent implantation in the “real world”: the rapamycin-eluting stent evaluated at rotterdam cardiology hospital (RESEARCH) registry.Circulation，2004，109 :190-195.
3 Stone GW，Ellis SG，Cox DA，et al.A polymer-based，paclitaxel-eluting stent in patients with coronary artery disease.N Engl J Med，2004，350:2212-2231.
4 Smith SC，Dove JT，Jacobs AK，et al.ACCIAHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines):a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.(Committee to revise the 1993 guidelines for percutaneoustransluminal coronary angioplasty).J Am Coll Cardiol，2001，37:2215-2239.
5 Zhang Q，Shen WF，Zhang JS，et al.Early and short-term clinical outcome of ACS MULTI-LINK PENTA coronary stent implantation.Interventional Radiology，2002，11:419-420.
6 Sino-SIRIUS研究组.国人应用雷帕霉素药物洗脱支架预防再狭窄的初步经验.中华心血管病杂志，2003，31:814-817.
7 Ruygrok PN，Muller DW，Serruys PW.Rapamycin in cardiovascular medicine.Intern Med J，2003，33(3):103-109.
8 Moses JW，Leon NB，Pomma JJ，et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.N Engl.J Med，2003，349: 1315-1323.
9 Morice MC，Serruys PW，Sousa JE，et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med，2002，346: 1773-1780.
10 Mckeage K，Murdoch D，Goa KL.The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease.Am J Cardiovasc Drugs，2003，3：211-230.
11 李光，周颖玲，陈纪言.雷帕霉素药物洗脱支架在冠心病患者中应用一年后的疗效.介入放射学杂志，2005，14: 15-17.
12 Iakovou I，Schmidt T，Bonizzoni E，et al.Incidence，predictors，and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA，2005，293 :2126-2130.
13 调查协作组.中国多中心药物洗脱支架急性或亚急性血栓的调查.中国介入心脏病学杂志，2005，13: 131上一页 [1] [2] [3] [4] [5] 下一页
上一个医学论文： 氯沙坦与吲哒帕胺单用和两药联合治疗老年高血压疗效比较
下一个医学论文： 呼吸内科病房院内肺部真菌感染的临床分析
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文